We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Analysis of the Cytomegalovirus Proteome Reveals Unanticipated Complexity

By LabMedica International staff writers
Posted on 05 Dec 2012
Advanced genomic and proteomic analysis techniques have been used for an in-depth study of the proteome of human Cytomegalovirus (HCMV), an incredibly successful pathogen that infects nearly everyone.

The huge 240,000 base pair HCMV genome was sequenced more than 20 years ago, but the viral proteome (the proteins encode by those genes) has not been studied in a comprehensive fashion. More...


Investigators at the University of California, San Francisco (USA) have now obtained much of the missing proteomic data. They used state-of-the-art ribosome profiling and transcript analysis linked to mass spectrometry to experimentally define the HCMV translation products (proteins) and follow their temporal expression. In translation, messenger RNA (mRNA) produced by transcription is decoded by the ribosomes to produce specific polypeptides that will later fold into active proteins.

Ribosome profiling is a technique that uses mRNA to determine what proteins are being translated. It produces a “global snapshot” of all the ribosomes active in the cell at a particular moment. Consequently, this enables researchers to identify the location of translation start sites, their distribution, and the speed of the translating ribosomes. Ribosome profiling derived from the old discovery that the mRNA within a ribosome can be isolated through the use of nucleases that degrade unprotected mRNA regions. This technique analyzes the ratio of multiple specific mRNAs to proteins being synthesized, to provide insight into global gene expression.

Results published in the November 23, 2012, issue of the journal Science revealed hundreds of previously unidentified open reading frames (sites of protein translation), a fraction of which were confirmed by means of mass spectrometry. Many of these open reading frames were found to encode for exceptionally short protein sequences (fewer than 100 amino acids), and some of the newly identified open reading frames were sequestered inside other open reading frames.

These results unveiled an unanticipated complexity to the HCMV coding capacity and illustrated the role of the regulated use of alternative transcript start sites in enabling tight temporal control of HCMV protein expression and allowing multiple distinct polypeptides to be generated from a single genomic locus.

"The genome of a virus is just a starting point," said senior author Dr. Jonathan Weissman, professor of cellular and molecular pharmacology and of biochemistry and biophysics at the University of California, San Francisco. "Understanding what proteins are encoded by that genome allows us to start thinking about what the virus does and how we can interfere with it… Each of the proteins we have identified has the potential to tell us how this virus is manipulating its host cell."

Related Links:
University of California, San Francisco


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Clinical Chemistry Analyzer
Envoy 500+
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: The method combines metagenomic sequencing with computational filtering to identify likely disease-causing bacteria and viruses (Image Credit: iStock)

Computational Filters Enhance Metagenomic Detection of Meningitis and Encephalitis

Infections of the central nervous system, such as meningitis and encephalitis, can be severe and require prompt diagnosis and treatment. Clinicians typically evaluate cerebrospinal fluid alongside symptoms... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.